Iron deficiency a new therapeutic target in heart failure?
18 November 2009
| by Nicola Garrett
Treatment with intravenous ferric carboxymaltose in patients with chronic heart failure and iron deficiency, with or without anaemia, improves symptoms, functional capacity, and quality of life, the FAIR-HF study has found....
Want to read complete article? Please Sign in or Register.